Corbus Pharmaceuticals Holdings (CRBP) EBITDA Margin Growth (1y) (2016 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) EBITDA Margin Growth (1y) (2016 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3,609.00 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1,536.00 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 59,597.00 |
| Jun 30, 2021 | 77,426.00 |
| Mar 31, 2021 | -80,123.00 |
| Dec 31, 2020 | -130,450.00 |
| Sep 30, 2020 | -186,652.00 |
| Jun 30, 2020 | -1.33 Mn |
| Mar 31, 2020 | -27,654.00 |
| Dec 31, 2019 | 884,691.00 |
| Sep 30, 2019 | 39,662.00 |
| Jun 30, 2019 | 145,772.00 |
| Mar 31, 2019 | -15,817.00 |
| Sep 30, 2018 | -49,206.00 |
| Jun 30, 2018 | 63,033.00 |
| Mar 31, 2018 | -67,230.00 |
| Sep 30, 2017 | -15,533.00 |
| Jun 30, 2017 | -102,530.00 |
| Mar 31, 2017 | 15,193.00 |
| Sep 30, 2016 | 60,460.00 |
| Jun 30, 2016 | 119,828.00 |